(AGENPARL) – WORCESTER (MASSACHUSETTS), lun 14 giugno 2021 (Virginia Commonwealth University) Through a pre-clinical study conducted in his former role at Moffitt Cancer Center and published in Clinical Cancer Research, Said Sebti, Ph.D., associate director for basic research at VCU Massey Cancer Center, identified a novel drug that effectively thwarts pancreatic tumors that are addicted to the cancer-causing mutant KRAS gene.

Fonte/Source: https://www.eurekalert.org/pub_releases/2021-06/vcu-tdf061421.php